Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Managed Care & Specialty Pharmacy|December 20, 2024
Impact of social determinants of health on esketamine nasal spray initiation among patients with treatment-resistant depression in the United StatesKristin Clemens, Maryia Zhdanava, Amanda Teeple, et al.
Neuropsychiatric Disease and Treatment|August 1, 2022
Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider SurveyMaryia Zhdanava, H Lynn Starr, Patrick Lefebvre, et al.
Advances in Therapy|August 20, 2024
Real-World Long-Term Persistence and Surgical Procedure-Free Period Among Bio-naïve Patients with Crohn's Disease and Fistula Initiated on UstekinumabMaryia Zhdanava, Sumesh Kachroo, Porpong Boonmak, et al.
Patient Preference and Adherence|April 15, 2024
Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative ColitisMaryia Zhdanava, Sumesh Kachroo, Aditi Shah, et al.
Neuropsychiatric Disease and Treatment|September 14, 2022
Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber SurveyMaryia Zhdanava, H Lynn Starr, Todor I Totev, et al.
Drugs - Real World Outcomes|January 19, 2025
Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USAManish K Jha, Maryia Zhdanava, Aditi Shah, et al.
The Journal of Pediatrics|December 3, 2014
The prevalence of congenital hearing loss in neonates with Down syndromeAdrienne S Tedeschi, Nancy J Roizen, H Gerry Taylor, et al.
Clinical Genetics|July 13, 2026
Atypical Prenatal Phenotypic Spectrum: A Case Series of Four Unique Presentations With Genetic and Diagnostic InsightsR Sahithi Rathod, Geeta Kolar, Suseela Vavilala, et al.
Clinical Therapeutics|October 7, 2022
Characteristics of Real-world Commercially Insured Patients With Treatment-resistant Depression Initiated on Esketamine Nasal Spray or Conventional Therapies in the United StatesSwapna Karkare, Maryia Zhdanava, Dominic Pilon, et al.
Chest|October 23, 2019
Redesigning Care for OSALucas M Donovan, Aditi Shah, Ching Li Chai-Coetzer, et al.
Pageof 6